Deleterious role of TNF-α in retinal ischemia-reperfusion injury

被引:65
作者
Berger, Samuel [1 ]
Savitz, Sean I. [2 ]
Nijhawan, Sheetal [1 ]
Singh, Manjeet [1 ]
David, Joel [1 ]
Rosenbaum, Pearl S. [3 ,4 ]
Rosenbaum, Daniel M. [1 ]
机构
[1] Suny Downstate Med Ctr, Dept Neurol, Brooklyn, NY 11203 USA
[2] Univ Texas Houston, Sch Med, Dept Neurol, Houston, TX USA
[3] Albert Einstein Coll Med, Montefiore Med Ctr, Dept Pathol, Bronx, NY 10467 USA
[4] Albert Einstein Coll Med, Bronx Lebanon Hosp Ctr, Dept Ophthalmol, Bronx, NY 10467 USA
关键词
D O I
10.1167/iovs.07-0817
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE. Tumor necrosis factor (TNF)-alpha is a mediator of neuronal cell death and survival in ischemia-reperfusion injury. This study was conducted to further elucidate the role of TNF-alpha and its receptor in an in vivo model of retinal ischemia reperfusion injury by investigating its effects on retinal histopathology and function. METHODS. Retinal ischemia-reperfusion injury was performed on p55 and p75 knockout (KO) mice and Sprague-Dawley rats using the high intraocular pressure method. The temporal expression of TNF-alpha was ascertained with immunohistochemical staining. Separate rats received intravitreal recombinant TNF-alpha or neutralizing antibody before or after ischemia. TUNEL labeling was performed to assess for cell death, and electroretinography was performed to assess function. RESULTS. TNF-alpha expression peaked at 12 to 24 hours after ischemia-reperfusion injury. TUNEL staining was diminished after intravitreal TNF-alpha antibody. Both transgenic KOs demonstrated significantly less functional impairment. Rats receiving recombinant TNF-alpha 48 hours after ischemia showed exaggerated functional impairment. Animals treated with TNF-alpha antibody before ischemia displayed significant functional improvement. CONCLUSIONS. TNF-alpha plays a largely deleterious role in ischemia -reperfusion injury in an in vivo model of retinal injury. Direct neutralization of this cytokine partially preserves retinal function. The diverse characteristics of TNF-alpha are attributed in part to the timing of its expression after injury. TNF-alpha receptor expression and function, along with combination treatments targeting death receptor-mediated apoptosis, should be further explored to develop neuroprotective therapeutic strategies for acute retinal ischemic disorders.
引用
收藏
页码:3605 / 3610
页数:6
相关论文
共 29 条
[1]   Tumor necrosis factor-alpha - A mediator of focal ischemic brain injury [J].
Barone, FC ;
Arvin, B ;
White, RF ;
Miller, A ;
Webb, CL ;
Willette, RN ;
Lysko, PG ;
Feuerstein, GZ .
STROKE, 1997, 28 (06) :1233-1244
[3]  
Downen M, 1999, GLIA, V28, P114, DOI 10.1002/(SICI)1098-1136(199911)28:2<114::AID-GLIA3>3.0.CO
[4]  
2-O
[5]  
FEUERSTEIN GZ, 1994, CEREBROVAS BRAIN MET, V6, P341
[6]   Neurodegenerative and neuroprotective effects of tumor necrosis factor (TNF) in retinal ischemia: Opposite roles of TNF receptor 1 and TNF receptor 2 [J].
Fontaine, V ;
Mohand-Said, S ;
Hanoteau, N ;
Fuchs, L ;
Pfizenmaier, K ;
Eisel, U .
JOURNAL OF NEUROSCIENCE, 2002, 22 (07)
[7]   Inhibition of tumor necrosis factor-α improves physiological angiogenesis and reduces pathological neovascularization in ischemic retinopathy [J].
Gardiner, TA ;
Gibson, DS ;
de Gooyer, TE ;
de la Cruz, VF ;
McDonald, DM ;
Stitt, AW .
AMERICAN JOURNAL OF PATHOLOGY, 2005, 166 (02) :637-644
[8]   THE TNF RECEPTOR 1-ASSOCIATED PROTEIN TRADD SIGNALS CELL-DEATH AND NF-KAPPA-B ACTIVATION [J].
HSU, HL ;
XIONG, J ;
GOEDDEL, DV .
CELL, 1995, 81 (04) :495-504
[9]   Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury [J].
Junk, AK ;
Mammis, A ;
Savitz, SI ;
Singh, M ;
Roth, S ;
Malhotra, S ;
Rosenbaum, PS ;
Cerami, A ;
Brines, M ;
Rosenbaum, DM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (16) :10659-10664
[10]   Contribution of TNF-α to leukocyte adhesion, vascular leakage, and apoptotic cell death in endotoxin-induced uveitis in vivo [J].
Koizumi, K ;
Poulaki, V ;
Doehmen, S ;
Welsandt, G ;
Radetzky, S ;
Lappas, A ;
Kociok, N ;
Kirchhof, B ;
Joussen, AM .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 (05) :2184-2191